← ANALYSTS · TIPRANKS

David Lebowitz · BMO Capital

#597among 12,504 TipRanks analysts★★★★★★★★★★
Hits 60% 195 of 327 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +14.2% Over a year after the rating, TipRanks’ measure
Our companies rated now 9 Buy / hold / sell: 7 / 2 / 0
Upside of the analyst’s targets +109.9% Average over 9 current targets, to the last price
The market’s answer to the ratings +1.2% Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 7on TipRanks 08:35 BCAXIWMBicara Therapeutics Inc. · $1.2B Reiterated Buy $35.00 +108.6% −0.6%next day +5.5% · 5 days +6.6%
Oct 6on TipRanks Oct 7 09:15 BMRNBioMarin Pharmaceutical · $10.8B Reiterated Buy $97.00 +77.4% −2.8%next day −1.6% · 5 days −3.1%
Sep 24on TipRanks Sep 25 09:15 PRMEIWMPrime Medicine, Inc. · $655M Reiterated Buy $9.00 +159.4% −1.8%next day −6.1% · 5 days −2.2%
Sep 23on TipRanks Sep 24 08:55 IONSIonis Pharmaceuticals · $7.0B Reiterated Hold $54.00 +25.8% −3.3%next day −0.2% · 5 days +2.3%
Sep 17on TipRanks Sep 18 08:55 ALNYQQQAlnylam Pharma · $31.3B Reiterated Buy $318 +37.2% +1.4%next day −2.6% · 5 days +0.8%
Sep 14on TipRanks Sep 15 10:25 ASNDAscendis Pharma · $13.9B Reiterated Buy $319 +41.6% +1.0%next day −9.0% · 5 days −12.2%
Sep 14on TipRanks Sep 15 10:25 CATXIWMPerspective Therapeutics · $267M Reiterated Buy $11.00 +406.9% +4.4%next day −6.0% · 5 days −0.2%
Sep 11on TipRanks Sep 14 10:45 EXELExelixis · $14.8B Reiterated Hold $54.00 −13.2% −3.1%next day +0.6% · 5 days +4.1%
Aug 18on TipRanks Aug 19 07:07 AKTSIWMAktis Oncology, Inc. · $890M Initiated Buy $37.00 +145.7% +1.8%next day −0.1% · 5 days +7.0%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗